We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Strength Seen in ResMed (RMD): Stock Soars 14.7%
ResMed Inc. (RMD - Free Report) was a big mover last session, as the company saw its shares rise more than 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $84.69 to $88.19 in the past one month time frame.
The move came after the company reported better-than-expected second-quarter fiscal 2018 results.
The company has not seen any estimate revisions in the past month, while the Zacks Consensus Estimate has moved higher over the said time period, suggesting that more solid trading could be ahead for ResMed. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
ResMed currently has a Zacks Rank #2 (Buy), while its Earnings ESP is positive.
ResMed Inc. Price
ResMed Inc. Price | ResMed Inc. Quote
Investors interested in the Medical - Products industry may consider Bio-Rad Laboratories, Inc. (BIO - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is RMD going up? Or down? Predict to see what others think: Up or Down
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>